| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.00073 | 1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0005 | 1 |